Abstract:Neuropathic pain (NP) is chronic pain caused by injury or disease of the sensory nervous system. At present, the pathogenesis of NP is not completely clear, and the treatment of NP is only limited to the management of pain symptoms, which seriously affects the quality of life of patients and brings a substantial economic burden to society. Metabonomics research is a new subject in modern biological research. It can detect the metabolic products of cells, tissues, or organs under pathological stimulation or gene modification, screen differential metabolic products, reverse explore diseases' metabolism and signal pathways, and find potential pathological mechanisms and therapeutic targets. At present, the metabonomic study of neuropathic pain has made great progress, opened up a new perspective for the study of neuropathic pain mechanism, and produced a lot of results. However, there are few relevant review reports at present. Therefore, this article aims to summarize and analyze the pathological mechanism and potential therapeutic targets of NP from the perspective of metabonomics by reviewing metabonomic-related technologies and the progress of metabonomics in neuropathic pain.